» Articles » PMID: 28411040

Occurrence of Hepatocellular Carcinoma in HIV/HCV Co-infected Patients Treated with Direct-acting Antivirals

Overview
Journal J Hepatol
Publisher Elsevier
Specialty Gastroenterology
Date 2017 Apr 16
PMID 28411040
Citations 4
Authors
Affiliations
Soon will be listed here.
Citing Articles

Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors.

Sarantis P, Trifylli E, Koustas E, Papavassiliou K, Karamouzis M, Papavassiliou A Int J Mol Sci. 2022; 23(21).

PMID: 36362398 PMC: 9655697. DOI: 10.3390/ijms232113612.


Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma: The debate continues - A mini-review.

Kassas M, Elbaz T, Salaheldin M, Abdelsalam L, Kaseb A, Esmat G J Adv Res. 2019; 17:43-48.

PMID: 31193326 PMC: 6526204. DOI: 10.1016/j.jare.2019.03.001.


Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows.

Guarino M, Sessa A, Cossiga V, Morando F, Caporaso N, Morisco F World J Gastroenterol. 2018; 24(24):2582-2595.

PMID: 29962815 PMC: 6021774. DOI: 10.3748/wjg.v24.i24.2582.


Human immunodeficiency virus infection and mortality risk among lung cancer patients: A systematic review and meta-analysis.

Wang Y, Shen X Medicine (Baltimore). 2018; 97(15):e0361.

PMID: 29642182 PMC: 5908612. DOI: 10.1097/MD.0000000000010361.